About: Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 June 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2007 (uk) im Juni 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 11 June 2007 (en) 2007 թվականի հունիսի 11-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu en xunu de 2007 (ast)
publication date	wds:Q80466898-32506DD7-88F4-42C3-9F8C-148EA90AA6E2
publication date	2007-06-11 00:00:00Z (xsd:dateTime)
exact match	wds:Q80466898-C9C68FD5-C171-43C2-AB02-2917C6BB2303
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705742
cites work	wds:Q80466898-01FE76F6-7E77-4093-A4B8-93875D68C8F5 wds:Q80466898-12D15A79-6FA7-47E8-811D-784E1E0FB6C7 wds:Q80466898-169CBD76-1C3E-4502-BFCD-3959EB31DEF0 wds:Q80466898-1A1A288B-734D-43B6-9473-EFA353BBAF54 wds:Q80466898-1C08BE77-1746-4808-950E-3E271F7B284F wds:Q80466898-2C22065B-80E0-4E7D-9C01-AD656EFA2F54 wds:Q80466898-30118C84-FA73-4A59-A906-DDD4101CA2D4 wds:Q80466898-3F9394CD-8C60-42CA-BA07-1F9A5D81AC3A wds:Q80466898-3F9C1A69-9B86-40EC-8F21-1E3D055B79DE wds:Q80466898-46EA1BF9-FDC9-4879-B91D-A92B5E676473 wds:Q80466898-479C8DE7-E1CF-4AE0-859C-93D3489EC23B wds:Q80466898-529211CC-D919-423E-BDB6-B693142A7701 wds:Q80466898-66FB0125-4447-4D6D-9273-0F414552F38B wds:Q80466898-7295E104-E5AC-4FF7-89E7-69AE8B1F3535 wds:Q80466898-7A573FBD-1A72-4693-B242-87CB67B4D06A wds:Q80466898-83B9D727-B3D7-4DBF-A2B0-36D9E8945664 wds:Q80466898-B639A605-E0C6-4278-A633-ED12C3A4A125 wds:Q80466898-F645B98D-0EF9-4A2B-B6FF-533B5506797C wds:Q80466898-FB9C8EA3-F35C-4944-94C7-7A4ADA94C109 wds:Q80466898-FDBBFA6D-DC97-47EF-A2AC-45C00B3B1669
cites work	Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation A comparison of allografting with autografting for newly diagnosed myeloma Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM). Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells
author name string	wds:Q80466898-6D0D1D4B-81C4-4288-9EE3-E1365AE69BCB wds:Q80466898-73005AC7-480A-4055-933F-AC2A5E5FFE56 wds:Q80466898-88DEE987-444E-4565-AC31-64BB4F50315A wds:Q80466898-B955DEB3-CD5B-4D2E-8E3F-8549D26B15D1 wds:Q80466898-E1BC0233-15F5-47FF-BF41-E2E51F853BF9
author name string	Raymakers RA Schattenberg AV Dolstra H Levenga H Levison-Keating S
rdfs:label	Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (en) Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (nl)
skos:prefLabel	Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (en) Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (nl)
name	Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (en) Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (nl)
author	wds:Q80466898-D3CB0DD4-D569-4CBF-814E-D9B8F37DC41A
author	Nicolaas Schaap
title	wds:Q80466898-F421FED0-B37C-4ADE-B568-0E2873BA0D6F
title	Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival (en)
page(s)	wds:Q80466898-17A57C36-B327-491C-9280-AF678D2713CB
page(s)	355-359
instance of	wds:Q80466898-A3A2DC64-E503-457B-B17E-0AF94B7EE8F8
instance of	scholarly article
main subject	wds:Q80466898-1AD61E15-1A25-4BA2-AEB1-426ABD47D172 wds:Q80466898-8FC155BE-8AEF-469D-BDC9-0531EC206201
main subject	multiple myeloma stem cell transplantation
PubMed ID	wds:Q80466898-A4540144-3940-46D2-8BE3-8AE370D8FC3A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17563732
PubMed ID	17563732
published in	wds:Q80466898-23806C0E-A7B3-4052-B166-F6838DF87795
published in	Bone Marrow Transplantation
issue	wds:Q80466898-320BEFF1-A5AC-440D-A1B7-13FD1010882B
volume	wds:Q80466898-2A138042-54F4-4280-95B9-7DB24AA9178C
issue	4
volume	40
DOI	wds:Q80466898-9DA8D67E-D70C-4394-8DC8-1053D1C13CA4
DOI	http://dx.doi.org/10.1038/SJ.BMT.1705742
DOI	10.1038/SJ.BMT.1705742
Dimensions Publication ID	wds:Q80466898-53A916F5-B4CE-442A-A16C-1E9FD3FF2534
Dimensions Publication ID	1024820750
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80466898
is cites work of	Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs. Role of allogeneic stem cell transplantation in multiple myeloma In vitro Generation of Cytotoxic T Cells With Potential for Adoptive Tumor Immunotherapy of Multiple Myeloma Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software